Advertisement

Topics

Pro-Trader Daily: Featured Company News - Eli Lilly Achieves Positive Results for Second Phase-3 Study of Lasmiditan, an Acute Migraine Treatment

07:45 EDT 7 Aug 2017 | FinanzNachrichten

LONDON, UK / ACCESSWIRE / August 7, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Eli Lilly & Co. (NYSE: LLY) ("Eli Lilly"), following which ...

Original Article: Pro-Trader Daily: Featured Company News - Eli Lilly Achieves Positive Results for Second Phase-3 Study of Lasmiditan, an Acute Migraine Treatment

NEXT ARTICLE

More From BioPortfolio on "Pro-Trader Daily: Featured Company News - Eli Lilly Achieves Positive Results for Second Phase-3 Study of Lasmiditan, an Acute Migraine Treatment"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...